Miltefosine to Treat Mucocutaneous Leishmaniasis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Knight Therapeutics (USA) Inc
ClinicalTrials.gov Identifier:
NCT01050907
First received: January 12, 2010
Last updated: March 24, 2015
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)